DNA-peptide conjugates are molecular chimeras with a nucleic acid portion and a polypeptide that are widely used in therapeutics and nanotechnology. CD Formulation provides custom synthesis and ligation of peptide and DNA oligomers to clients worldwide. DNA oligomers are conjugated to peptides via functionalized phosphoramidite monomers, the most common reactive moieties being amines, thiols, alkoxyamines or hydrazines, aldehydes, azides/alkynes.
DNA-conjugated peptides, also known as DNA-peptide conjugates are chimeric molecules composed of nucleic acid parts covalently linked to peptides. Potential applications of DNA-peptide constructs range from therapy to nanotechnology. A common DNA-peptide conjugation strategy is to combine cell-penetrating peptides with phosphosulfate DNA chains to enhance nuclease attack. When combined with peptides, DNA is more resistant to nucleases, and when linked to cationic peptides, double-strand formation can be enhanced. In addition, DNA-peptide conjugates have been used in a variety of sensing systems.
Fig. 1 Synthesis pathway to achieve DNA–peptide conjugates by solution phase modification. (Taylor ER, et al., 2022)
CD Formulation offers several custom synthesis options for peptides and DNA listed below, but we are happy to discuss conjugation projects using your own DNA or peptides.
The conjugation of these macromolecules to peptides is often hampered by side reactions. To overcome this difficulty, we use different synthetic methods for the chemical synthesis of DNA-peptide conjugates. The two most common approaches are:
Stepwise synthesis is an online solid-phase synthesis protocol in which peptides and oligonucleotides are synthesized sequentially, usually on the same solid support.
Post-synthesis conjugation is a chemoselective ligation reaction that introduces reactive groups to oligonucleotides and peptides. This strategy includes the formation of a variety of bonds, such as amide, disulfide, oxime, carbonyl, or cycloaddition click reactions.
At CD Formulation, both peptides and DNA are synthesized independently using standard Boc or Fmoc chemistry. Then the peptide or oligonucleotide is immobilized on a solid support and conjugated after synthesis. The intact oligonucleotide-peptide conjugate is cleaved from the support.
Fig. 2 Schematic diagram of DNA and peptide conjugation. (CD Formulation)
The N-terminus or C-terminus of the peptide often emerges as a favored locus for the attachment to the 3' or 5' extremities of DNA strands. This sophisticated methodology hinges upon the nuanced interaction of N- or C-terminally cysteine-conjugated peptides engaging in a reactive liaison with maleimide-activated DNA. The most common options for conjugation are:
If the peptide has an internal Cys, we will use other strategies such as oxime formation by reacting hydroxylamine-modified peptides with aldehyde-modified oligonucleotides.
Our experts use copper-free click chemistry to conjugate alkyne-modified DNA oligonucleotides to azide-modified peptides to form DNa-conjugated peptides.
Modifications can be incorporated into the DNA or peptide molecules, or both molecules (if appropriate). Modifications include:
Delivery Specifications of DNA-Conjugated Peptide
Requirements | Description |
Length |
|
Purity |
|
Modification | Customized modification service according to customer requirements, including:
|
Form | Lyophilized sample in individual fully labeled vials. |
Quality Control (QC) | COA, MS, HPLC and/or other analytical data. |
Longer peptide oligonucleotide sequences are available upon request. |
In addition to peptide synthesis capabilities, CD Formulation combines flexible GMP manufacturing facilities with cutting-edge peptide analytical knowledge to provide a full range of quality control testing services to accelerate the commercialization of your products, including:
Published Data
Technology: Solid-Phase Fragment Condensation
Journal: Nucleosides, Nucleotides & Nucleic Acids.
IF: 1.1
Published: 2003
Results:
The authors designed and developed a new method for preparing DNA-peptide conjugates by solid-phase fragment condensation. This method successfully conjugates oligonucleotides to various functional molecules on the solid phase, including amino, hydroxyl, thiol, and carboxyl groups. Pure DNA-peptide conjugates were obtained by RP-HPLC purification. On this basis, the authors also demonstrated the effectiveness of this method for preparing conjugate molecules, DNA-sugar, DNA-polyamine, DNA-lipid, etc.
Fig. 3 Synthesis of DNA conjugate by solid phase fragment condensation. (Anno Y, et al., 2003)
CD Formulation is a trusted partner for peptide synthesis. Please don't hesitate to contact us if you are considering using DNA-conjugated peptides in your project. We look forward to cooperating with you.
References